君实生物2025年第三季度净利润亏损1.83亿元

Core Insights - Junshi Biosciences reported a revenue of 637 million yuan for Q3 2025, marking a year-on-year increase of 31.4% [2] - The net profit attributable to shareholders for Q3 2025 was a loss of 183 million yuan [2] - For the first three quarters of 2025, the company achieved a total revenue of 1.806 billion yuan, reflecting a year-on-year growth of 42.06% [2] - The net profit attributable to shareholders for the first three quarters was a loss of 596 million yuan [2]